PharmaShots Weekly Snapshots (May 03 – 07, 2021)

 PharmaShots Weekly Snapshots (May 03 – 07, 2021)

PharmaShots Weekly Snapshots (May 03 – 07, 2021)

AstraZeneca Reports Results of Imfinzi (durvalumab) and Imfinzi + Tremelimumab in P-III POSEIDON Study as 1L Treatment for Stage IV Non-Small Cell Lung Cancer

Published: May 7, 2021 | Tags: AstraZeneca, Imfinzi, durvalumab, Tremelimumab, P-III, POSEIDON Study, Stage IV Non-Small Cell Lung Cancer

Merck and Fusion Pharmaceuticals Enter into a Clinical Collaboration for FPI-1434 + Keytruda (pembrolizumab) to Treat Solid Tumors Expressing IGF-1R

Published: May 7, 2021 | Tags: Merck, Fusion Pharmaceuticals, FPI-1434, Keytruda, pembrolizumab, Solid Tumors, IGF-1R

BMS Signs a Research Collaboration with DarwinHealth to Discover Novel Cancer Target Initiative

Published: May 7, 2021 | Tags: BMS, DarwinHealth, Novel Cancer Target Initiative

BeiGene and Asieris Enter into Clinical Collaboration for APL-1202 + Tislelizumab to Treat Muscle Invasive Bladder Cancer

Published: May 7, 2021 | Tags: BeiGene, Asieris, APL-1202, Tislelizumab, Muscle Invasive Bladder Cancer

AbCellera Signs a Multi-Target Collaboration with Amgen to Develop Bispecific Antibodies for the Treatment of Diabetic Retinopathy

Published: May 7, 2021 | Tags: AbCellera, Amgen, Bispecific Antibodies, Diabetic Retinopathy

Merck and Eisai Receive the US FDA‘s Priority Review for Keytruda (pembrolizumab) + Lenvima (lenvatinib) Applications to Treat Advanced Renal Cell Carcinoma and Endometrial Carcinoma

Published: May 7, 2021 | Tags: Merck, Eisai, US, FDA, Priority Review, Keytruda, pembrolizumab, Lenvima, Lenvatinib, Applications, Advanced Renal Cell Carcinoma, Endometrial Carcinoma

Amgen Reports the US FDA’s Acceptance of sNDA for Review of Otezla (apremilast) to Treat Mild-To-Moderate Plaque Psoriasis

Published: May 6, 2021 | Tags: Amgen, US, FDA, Acceptance, sNDA, Review, Otezla, apremilast, Plaque Psoriasis

Roche’s Ab Cocktail (Casirivimab and Imdevimab) Receives EUA to Treat COVID-19 in India

Published: May 6, 2021 | Tags: Roche, Ab Cocktail, Casirivimab, Imdevimab, EUA, COVID-19

Sanofi Signs a Three-Year Collaboration with Stanford Medicine to Accelerate Immunology Research

Published: May 6, 2021 | Tags: Sanofi, Stanford Medicine, Accelerate, Immunology Research

Medtronic Launches CareGuidePro App for Managing Spinal Cord Stimulation

Published: May 6, 2021 | Tags: Medtronic, CareGuidePro App, Managing, Spinal Cord Stimulation

Phenomix Collaborates with Mayo Clinic for AI-Powered Obesity Phenotype Blood Test

Published: May 6, 2021 | Tags: Phenomix, Mayo Clinic, AI-Powered, Obesity, Phenotype Blood Test

GSK’s Benlysta (belimumab) Receives EC’s Approval for the Treatment of Active Lupus Nephritis

Published: May 6, 2021 | Tags: GSK, Benlysta, belimumab, EC, Approval, Active Lupus Nephritis

Exelixis Acquires GamaMabs’ Oncology Antibody Program to Expand its Biotherapeutics Portfolio

Published: May 5, 2021 | Tags: Exelixis, GamaMabs, Oncology Antibody Program, Biotherapeutics Portfolio

ProQR Therapeutics Signs an Exclusive Worldwide License Agreement with Yarrow to Develop Therapies for Non-Ophthalmic Target

Published: May 5, 2021 | Tags: ProQR Therapeutics, Yarrow, Therapies, Non-Ophthalmic Target

AbCellera to Initiate Clinical Trial of LY-CoV1404 Against Viral Variants of COVID 19

Published: May 5, 2021 | Tags: AbCellera, Clinical Trial, LY-CoV1404, Against, Viral Variants, COVID 19

Amgen Launches Amgevita (biosimilar, adalimumab) for the Treatment of Multiple Chronic Inflammatory Diseases in Canada

Published: May 5, 2021 | Tags: Amgen, Amgevita, biosimilar, adalimumab, Multiple Chronic Inflammatory Diseases

Roche’s Tecentriq Receives EC’s Approval as 1L Treatment for Metastatic Non-Small Cell Lung Cancer

Published: May 5, 2021 | Tags: Roche, Tecentriq, EC, Approval, Metastatic Non-Small Cell Lung Cancer

Athenex to Acquire Kuur Therapeutics for ~$185M

Published: May 5, 2021 | Tags: Athenex, Kuur Therapeutics, ~$185M

Vaxart Reports News Data of VXA-CoV2-1 (Oral COVID-19 Vaccine) in P-I Trial Against Other Coronaviruses

Published: May 4, 2021 | Tags: Vaxart, VXA-CoV2-1, Oral COVID-19 Vaccine, P-I, Trial, Against, Other Coronaviruses

Novavax Reports the Pediatric Expansion for P-III Clinical Trial of NVX-CoV2373 Against COVID-19

Published: May 4, 2021 | Tags: Novavax, Pediatric Expansion, P-III, Clinical Trial, NVX-CoV2373, COVID-19

BMS Presents Clinical and RWE Data of Mavacamten for Obstructive Hypertrophic Cardiomyopathy at ACC 2021

Published: May 4, 2021 | Tags: BMS, Mavacamten, Obstructive Hypertrophic Cardiomyopathy, ACC 2021

Sandoz Initiates Patient Enrolment of Proposed Biosimilar Aflibercept in P-III MYLIGHT Study for Neovascular Age-Related Macular Degeneration

Published: May 4, 2021 | Tags: Sandoz, Proposed, Biosimilar, Aflibercept, P-III, MYLIGHT Study,  Neovascular Age-Related Macular Degeneration

Labcorp to Acquire Myriad’s Vectra Testing Business for $150M

Published: May 4, 2021 | Tags: Labcorp, Myriad, Vectra Testing Business, $150M

Roivant Going Public Via MAAC SPAC Merger for ~$7.3B

Published: May 4, 2021 | Tags: Roivant, MAAC SPAC, Merger,~$7.3B

Eli Lilly and Incyte Present New Data of Olumiant (baricitinib) in P-III BREEZE-AD5 Trial Moderate to Severe Atopic Dermatitis at AAD2021

Published: May 3, 2021 | Tags: Eli Lilly, Incyte, Olumiant, baricitinib, P-III, BREEZE-AD5 Trial, Atopic Dermatitis, AAD2021

Guardant Health Reports Results of Blood-Only Liquid Biopsy Test Predicting Risk of Colorectal Cancer Recurrence

Published: May 3, 2021 | Tags: Guardant Health, Blood-Only, Liquid Biopsy Test, Colorectal Cancer Recurrence

Sobi and Hellenic Institute Report Results of Anakinra in P-III SAVE-MORE Study for Hospitalized Patients with COVID-19 Pneumonia

Published: May 3, 2021 | Tags: Sobi, Hellenic Institute, Anakinra, P-III, SAVE-MORE Study, COVID-19 Pneumonia

Novartis Presents Results of Beovu (brolucizumab -dbll) in P-III KESTREL and KITE Studies for Diabetic Macular Edema at ARVO2021

Published: May 3, 2021 | Tags: Novartis, Beovu, brolucizumab -dbll, P-III, KESTREL, KITE Studies,  Diabetic Macular Edema, ARVO2021

Samsung Bioepis Presents Results of SB11 (proposed biosimilar ranibizumab) at ARVO 2021

Published: May 3, 2021 | Tags: Samsung Bioepis, SB11, biosimilar, ranibizumab, ARVO 2021

AstraZeneca’s Farxiga (dapagliflozin) Receives the US FDA’s Approval for Chronic Kidney Disease

Published: May 3, 2021 | Tags: AstraZeneca, Farxiga, dapagliflozin, US, FDA, Approval, Chronic Kidney Disease
Related Post: PharmaShots Weekly Snapshots (Apr 26 – 30, 2021)

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post